drugset / Trial / NCT04356170
Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma
Phase 2
Completed
105 enrolled
Groupe Oncologie Radiotherapie Tete et Cou
Centre Leon Berard · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the efficacity of the combination of cisplatin-5-FU and docetaxel in adapted doses in term of response to treatment without toxicity .
Timeline
- Start
- 2021-02-04
- Primary completion
- 2025-08-05
- Completion
- 2025-08-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 75 mg/m2 | Intravenous |
| Subject | Docetaxel | Small molecule | 75 mg/m2 | Intravenous |
| Subject | fluorouracil | Small molecule | 750 mg/m2 | Intravenous |